You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

BIAXIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Biaxin patents expire, and what generic alternatives are available?

Biaxin is a drug marketed by Abbvie and is included in three NDAs.

The generic ingredient in BIAXIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Biaxin

A generic version of BIAXIN was approved as clarithromycin by ACTAVIS LABS FL INC on June 24th, 2004.

  Try a Trial

Summary for BIAXIN
US Patents:0
Applicants:1
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 86
Clinical Trials: 48
Patent Applications: 2,317
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in BIAXIN?BIAXIN excipients list
DailyMed Link:BIAXIN at DailyMed
Drug patent expirations by year for BIAXIN
Recent Clinical Trials for BIAXIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Emory UniversityPhase 2
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2
National Institute of Neurological Disorders and Stroke (NINDS)Phase 1/Phase 2

See all BIAXIN clinical trials

US Patents and Regulatory Information for BIAXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie BIAXIN clarithromycin FOR SUSPENSION;ORAL 050698-001 Dec 23, 1993 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie BIAXIN clarithromycin TABLET;ORAL 050662-001 Oct 31, 1991 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie BIAXIN clarithromycin FOR SUSPENSION;ORAL 050698-003 Sep 30, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie BIAXIN clarithromycin FOR SUSPENSION;ORAL 050698-002 Dec 23, 1993 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.